—

DAFNA Capital Management LLC

Q1 2026 13F Holdings

  • Location
    los angeles, CA
  • Num holdings

    83

  • Value ($000)

    $439,592

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001389933
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$56.47M
13 %

580,678

K
KRE

SPDR S&P BIOTECH ETF

ETF
78464A870
$40.68M
9 %

318,505

R
RJR1

STEREOTAXIS INC

COM NEW
85916J409
$25.17M
6 %

13,680,554

D
DAWN

DAY ONE BIOPHARMACEUTICALS I

COM
23954D109
$20.98M
5 %

978,463

A
ATRC

ATRICURE INC

COM
04963C209
$17.04M
4 %

597,431

I
IDYA

IDEAYA BIOSCIENCES INC

COM
45166A102
$15.88M
4 %

476,740

---

XENON PHARMACEUTICALS INC

COM
98420N105
$14.58M
3 %

250,772

C
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$14.34M
3 %

217,497

C
CMPS

COMPASS PATHWAYS PLC

SPONSORED ADS
20451W101
$13.38M
3 %

2,418,882

---

NEKTAR THERAPEUTICS

COM NEW
640268306
$11.88M
3 %

165,178

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 83